The committee are delighted to be able to advise that so far confirmed for the 4th European NF-κB Subunit Workshop are the following keynote speakers:

Sankar Ghosh

Sankar Ghosh, Ph.D., is the Silverstein and Hutt Family Professor of Microbiology and Chairman of the Department of Microbiology and Immunology at Columbia University in New York City.

Dr. Ghosh received his Ph.D. in Molecular Biology from the Albert Einstein College of Medicine in 1988. He did his postdoctoral research training with Nobel Laureate Dr. David Baltimore at the Whitehead Institute at MIT in Cambridge, MA. It was there that Dr. Ghosh began his seminal work in understanding the regulation of Nuclear Factor-kappa B (NF-kappa B / NF-κB), a transcription factor that plays a critical role in regulating the expression of a large number of genes involved in the mammalian immune system. Dr. Ghosh’s research led to the publication of multiple papers in premier scientific journals, including Nature, Cell, and Science. This period in his training was critical to launching his independent career.

Dr. Ghosh began his independent research career at Yale University School of Medicine in 1991, and was a Professor in the Departments of Immunobiology and Molecular Biophysics & Biochemistry, and an Investigator of the Howard Hughes Medical Institute, before being recruited to Columbia University in 2008 to head the Department of Microbiology & Immunology. An immunologist and biochemist, Dr. Ghosh continues to be best known for his work on NF-κB. Because NF-κB plays an important role in regulating the expression of a number of genes involved in inflammation and the immune responses, his research has implications for the treatment of arthritis, colitis, dermatitis, asthma, and other inflammatory diseases, as well as diseases such as cancer and muscular dystrophy.

In recognition of his many years of focus on illuminating the NF-kappa-B immune response pathway, Dr. Ghosh was elected in 2008 as a fellow of the American Association for the Advancement of Sciences. Dr. Ghosh’s other professional honors include a MERIT Award from the National Institutes of Health (2001), the Pharmingen Investigator Award from the American Association of Immunologists (2002), Ranbaxy Science Foundation Award (2006), the F. W. Alt Award for New Discoveries in Immunology from the Cancer Research Institute (2008), American Association of Indian Scientists in Cancer Research-Outstanding Scientist Award (2010), and the Distinguished Alumni Award of Albert Einstein College of Medicine, New York (2017).

In addition, Dr. Ghosh has served in an advisory capacity for several organizations, including the Board of Scientific Counselors of the National Cancer Institute, the Advisory Board of the Center on Immune Receptors at the Karolinska Institute in Stockholm, Sweden, the Board of Management of the National Center for Biological Sciences in Bangalore, India; the Scientific Review Board of the Damon Runyon Cancer Research Foundation; and the Scientific Review Council of the Leukemia and Lymphoma Society, Scientific Advisory Committee of Center for Life Sciences (CLS) of Peking University-Tsinghua University, Beijing and Scientific Advisory Board of Institute of Immunology, Jiaotong University, Shanghai. He has also served and is serving on the editorial board of multiple journals, including Immunity, Molecular and Cellular Biology, Journal of Biological Chemistry and Science Signaling.

Vinay Tergaonkar

Vinay Tergaonkar obtained his Ph.D. (2001) through an international cancer society (UICC) fellowship for collaborative research at Tufts University, Boston, USA. He has been a fellow (2001-2004) and a special fellow (2004-present) of the Leukemia and Lymphoma Society of America and conducted his postdoctoral studies at the Salk Institute for Biological Studies, La Jolla, California. He joined the Institute of Molecular and Cell Biology (IMCB), Singapore, in late 2005 as Principal Investigator and became a Senior Principal Investigator in 2010 and Research Director in 2015. He is also a Professor at School of Medicine at National University of Singapore. He serves on Editorial Boards of 1) Molecular and Cellular Biology (American Society for Molecular Biology) 2) Biochemical Journal (Portland Press) 
3) Critical Reviews in Oncology/Hematology (Elsevier Press), 4) BMC Research Notes (Biomed Central), 5) Telomeres and Telomerase and 6) Science Advances (AAAS). Work from his lab has received international recognition including the British council development award (2014) and the Premiers’ fellowship from Government of South Australia (2015).

Thomas Gilmore

Tom Gilmore, PhD, is a Professor of Biology at Boston University (BU). Dr. Gilmore received his PhD from the University of California, Berkeley, performed post-doctoral research at the McArdle Laboratory for Cancer Research at the University of Wisconsin, and has been a faculty member at BU since 1987. The Gilmore lab has been a key contributor to many aspects of NF-κB biology for the past 30 years, starting with his postdoctoral studies on the v-Rel oncoprotein with the late Dr. Howard Temin. Dr. Gilmore lab’s long-standing research interest has been in the area of NF-κB signaling and immune diseases, including human B-cell lymphoma and immunodeficiencies, and more recently, the role that NF-κB may play in environtmetnal disease pathologies of marine invertebrates such as corals and sea anemones. Dr. Gilmore’s research has been supported by grants from the NIH, NSF, the American Cancer Society, and several private agencies. In addition to research papers, Dr. Gilmore has written numerous general and specific reviews on NF-κB, and his lab hosts the web site nf-kb.org, which includes lists and databases on target genes and NF-κB inhibitors. Dr. Gilmore has carried out his research primarily with an army of student trainees, including 26 PhD students, 41 MA students and over 100 undergraduates. He has taught numerous graduate and undergraduate courses, and has received BU’s highest awards for teaching and research. He has also championed undergraduate research, including being Director of the University-wide Undergraduate Research Opportunities Program (UROP) for several years, and being PI on long-term grants from the Beckman Foundation and the NSF to support undergraduate research at BU.

We are pleased to announce that the following speakers have also confirmed their attendance:

Ruardhi Carmody, UK
Lienhard Schmitz, Germany
Simona Saccani, France
Michael Hottiger, Switzerland
Anne Puel, France
Neil Perkins, UK
Caroline Wilson, UK
Sonia Rocha, UK
Claus Scheidereit, Germany
Nicolas Matt, France
Kenneth Marcu, USA/Greece
Veronique Baud, France
Nuno Dos Santos, Portugal
Mariagrazia Grilli, Italy
Mike White, UK

Josephine Lampe, Germany
Lluis Espinosa, Spain
Benedict Seddon, UK
Ronny Haenold, Germany
Lesley Stark, UK